Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 13, 2026

After a -1.92% decline, Dr Reddys Laboratories Ltd shares are now trading at 1293.70. The stock has a PE ratio of 19.9300, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd plunged by -1.92%, leaving investors concerned. At this moment, the stock can be acquired at 1293.70, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd share price has declined by -2.00%, and it's currently trading at 1292.60. The stock maintains a PE of 19.9300, while the industry PE is 32.8605, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd has plummeted by -2.00%, signalling a challenging period. Currently trading at 1292.60, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Dr Reddys Laboratories Ltd has experienced a -2.65% drop, and it's now trading at 1284.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd shares saw a decrease of -2.65%, reaching a current market price of 1284.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd suffered a -1.43% decline, and it currently trades at 1300.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -1.43% in its share price, and it currently trades at 1300.20 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd experienced a -1.74% slump and is currently trading at 1296.00. While the stock maintains a PE ratio of 19.9300, the industry PE is 32.8605, raising questions about valuation.

Dr Reddys Laboratories Ltd share price has declined by -1.74%, and it's currently trading at 1296.00. The stock maintains a PE of 19.9300, while the industry PE is 32.8605, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd stock price decreased by -1.71%, with the current market value at 1296.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd observed a -1.71% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1296.50. The stock has a PE ratio of 19.9300, an ROE of 16.0277 and a debt to equity ratio of 0.1625.